vs
PCB BANCORP（PCB）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是PCB BANCORP的1.2倍（$35.5M vs $29.2M），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 11.3%），PCB BANCORP自由现金流更多（$24.4M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 10.4%）
PCB BANCORP旗下的PCB银行是一家总部位于加利福尼亚州的美国社区银行，主要服务韩裔美国社群，提供商业银行服务，目前在全美8个州设有分支机构，规模在韩资背景美国银行中位列第三，仅次于希望银行与韩美银行。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
PCB vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.2倍
$29.2M
营收增速更快
RXRX
高出670.4%
11.3%
自由现金流更多
PCB
多$71.7M
$-47.3M
两年增速更快
RXRX
近两年复合增速
10.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $29.2M | $35.5M |
| 净利润 | — | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 45.0% | -304.8% |
| 净利率 | — | -304.2% |
| 营收同比 | 11.3% | 681.7% |
| 净利润同比 | — | 39.6% |
| 每股收益（稀释后） | $0.65 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PCBRXRX
| Q4 25 | $29.2M | $35.5M | ||
| Q3 25 | $30.4M | $5.2M | ||
| Q2 25 | $29.3M | $19.2M | ||
| Q1 25 | $26.9M | $14.7M | ||
| Q4 24 | $26.2M | $4.5M | ||
| Q3 24 | $25.3M | $26.1M | ||
| Q2 24 | $24.2M | $14.4M | ||
| Q1 24 | $23.9M | $13.8M |
净利润PCBRXRX
| Q4 25 | — | $-108.1M | ||
| Q3 25 | $11.4M | $-162.3M | ||
| Q2 25 | $9.1M | $-171.9M | ||
| Q1 25 | $7.7M | $-202.5M | ||
| Q4 24 | — | $-178.9M | ||
| Q3 24 | $7.8M | $-95.8M | ||
| Q2 24 | $6.3M | $-97.5M | ||
| Q1 24 | $4.7M | $-91.4M |
毛利率PCBRXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率PCBRXRX
| Q4 25 | 45.0% | -304.8% | ||
| Q3 25 | 52.3% | -3327.6% | ||
| Q2 25 | 43.3% | -916.8% | ||
| Q1 25 | 40.2% | -1297.9% | ||
| Q4 24 | 39.3% | -4042.4% | ||
| Q3 24 | 42.2% | -377.1% | ||
| Q2 24 | 36.3% | -697.4% | ||
| Q1 24 | 27.2% | -698.4% |
净利率PCBRXRX
| Q4 25 | — | -304.2% | ||
| Q3 25 | 37.5% | -3135.3% | ||
| Q2 25 | 31.0% | -894.2% | ||
| Q1 25 | 28.8% | -1373.3% | ||
| Q4 24 | — | -3935.5% | ||
| Q3 24 | 30.8% | -367.5% | ||
| Q2 24 | 25.9% | -676.6% | ||
| Q1 24 | 19.6% | -662.4% |
每股收益（稀释后）PCBRXRX
| Q4 25 | $0.65 | $-0.17 | ||
| Q3 25 | $0.78 | $-0.36 | ||
| Q2 25 | $0.62 | $-0.41 | ||
| Q1 25 | $0.53 | $-0.50 | ||
| Q4 24 | $0.46 | $-0.56 | ||
| Q3 24 | $0.52 | $-0.34 | ||
| Q2 24 | $0.43 | $-0.40 | ||
| Q1 24 | $0.33 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $207.1M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $390.0M | $1.1B |
| 总资产 | $3.3B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资PCBRXRX
| Q4 25 | $207.1M | $743.3M | ||
| Q3 25 | $369.5M | $659.8M | ||
| Q2 25 | $263.6M | $525.1M | ||
| Q1 25 | $214.3M | $500.5M | ||
| Q4 24 | $198.8M | $594.4M | ||
| Q3 24 | $193.1M | $427.6M | ||
| Q2 24 | $177.6M | $474.3M | ||
| Q1 24 | $239.8M | $296.3M |
总债务PCBRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益PCBRXRX
| Q4 25 | $390.0M | $1.1B | ||
| Q3 25 | $384.5M | $1.0B | ||
| Q2 25 | $376.5M | $919.1M | ||
| Q1 25 | $370.9M | $933.9M | ||
| Q4 24 | $363.8M | $1.0B | ||
| Q3 24 | $362.3M | $524.6M | ||
| Q2 24 | $353.5M | $584.4M | ||
| Q1 24 | $350.0M | $401.2M |
总资产PCBRXRX
| Q4 25 | $3.3B | $1.5B | ||
| Q3 25 | $3.4B | $1.4B | ||
| Q2 25 | $3.3B | $1.3B | ||
| Q1 25 | $3.2B | $1.3B | ||
| Q4 24 | $3.1B | $1.4B | ||
| Q3 24 | $2.9B | $726.5M | ||
| Q2 24 | $2.9B | $775.9M | ||
| Q1 24 | $2.9B | $557.8M |
负债/权益比PCBRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $26.6M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $24.4M | $-47.3M |
| 自由现金流率自由现金流/营收 | 83.6% | -133.1% |
| 资本支出强度资本支出/营收 | 7.5% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $46.0M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流PCBRXRX
| Q4 25 | $26.6M | $-46.1M | ||
| Q3 25 | $16.4M | $-117.4M | ||
| Q2 25 | $4.9M | $-76.4M | ||
| Q1 25 | $2.3M | $-132.0M | ||
| Q4 24 | $39.0M | $-115.4M | ||
| Q3 24 | $11.9M | $-59.2M | ||
| Q2 24 | $14.6M | $-82.2M | ||
| Q1 24 | $8.2M | $-102.3M |
自由现金流PCBRXRX
| Q4 25 | $24.4M | $-47.3M | ||
| Q3 25 | $16.2M | $-117.6M | ||
| Q2 25 | $3.8M | $-79.6M | ||
| Q1 25 | $1.6M | $-133.8M | ||
| Q4 24 | $34.9M | $-116.7M | ||
| Q3 24 | $11.9M | $-63.8M | ||
| Q2 24 | $12.8M | $-83.4M | ||
| Q1 24 | $6.0M | $-109.0M |
自由现金流率PCBRXRX
| Q4 25 | 83.6% | -133.1% | ||
| Q3 25 | 53.2% | -2272.5% | ||
| Q2 25 | 13.1% | -413.9% | ||
| Q1 25 | 6.0% | -907.4% | ||
| Q4 24 | 133.2% | -2567.7% | ||
| Q3 24 | 46.8% | -244.6% | ||
| Q2 24 | 53.1% | -578.5% | ||
| Q1 24 | 25.2% | -789.9% |
资本支出强度PCBRXRX
| Q4 25 | 7.5% | 3.5% | ||
| Q3 25 | 0.8% | 4.7% | ||
| Q2 25 | 3.7% | 16.4% | ||
| Q1 25 | 2.8% | 12.4% | ||
| Q4 24 | 15.5% | 28.6% | ||
| Q3 24 | 0.1% | 17.5% | ||
| Q2 24 | 7.3% | 8.2% | ||
| Q1 24 | 9.3% | 48.2% |
现金转化率PCBRXRX
| Q4 25 | — | — | ||
| Q3 25 | 1.44× | — | ||
| Q2 25 | 0.54× | — | ||
| Q1 25 | 0.30× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 2.33× | — | ||
| Q1 24 | 1.76× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
